Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | 
|---|---|---|---|---|
| 1 | ||||
| Anaphylactic shock | Anaphylactic shock | x | ||
| Angioedema | Angioedema | x | ||
| Dyspnoea | Dyspnoea | x | ||
| Hypotension | Hypotension | x | ||
| Pruritus | Pruritus | x | ||
| Urticaria | Urticaria | x | ||
| Venous occlusion | Venous occlusion | x | ||
| Generalised erythema | Generalised erythema | x | ||
| Hypersensitivity | Systemic allergic reaction | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Hypersensitivity | x | |||
| Sensitisation | x | |||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |